Valeant completes tender offer for Obagi Medical

Valeant (VRX) announced the expiration of the tender offer a subsidiary of Valeant to purchase all of the outstanding shares of Obagi Medical (OMPI) for a price of $24 per share in cash, without interest. The offer expired at midnight on April 25. As a result of the merger, Obagi will become a wholly owned subsidiary of VPI.

View Comments (0)